psoriasis

Expression dynamics of cytokine genes is related to the apremilast treatment effectiveness in patients with severe psoriasis

Year & Volume - Issue: 
2024. volume 13 - Issue 1
Authors: 
Dmitry A. Verbenko, Arfenya E. Karamova, Olga G. Artamonova, Irina V. Kozlova, Dmitry G. Deryabin, Victoria S. Solomka, Alexey A. Kubanov
Heading: 
Dermatology
Article type: 
Original article
Keywords: 
apremilast, psoriasis, gene expression, therapy outcome, cytokine
CID: 
e0110
DOI: 
10.15275/rusomj.2024.0110
PDF File: 
PDF icon romj-2024-0110.pdf

The effect of apremilast therapy on skin cytokine levels in patients with psoriasis

Year & Volume - Issue: 
2020. volume 9 - Issue 3
Authors: 
Alexey A. Kubanov, Viktoria S. Solomka, Arfenya E. Karamova, Dmitry A. Verbenko, Elena L. Vasileva, Olga G. Artamonova
Heading: 
Dermatology
Article type: 
Original article
Keywords: 
psoriasis, cytokines, apremilast, phosphodiesterase-4 inhibitor
CID: 
e0310
DOI: 
10.15275/rusomj.2020.0310
PDF File: 
PDF icon romj-2020-0310.pdf

Experience of using secukinumab in treatment of severe refractory psoriasis: a clinical case

Year & Volume - Issue: 
2019. volume 8 - Issue 2
Authors: 
Nikolay V. Kungurov, Yulia V. Keniksfest, Muza M. Kokhan, Tatyana A. Syrneva, Elena V. Grishaeva
Heading: 
Dermatology
Article type: 
Case report
Keywords: 
psoriasis, systemic therapy, genetically engineered biological therapy, quality of life
CID: 
e0209
DOI: 
10.15275/rusomj.2019.0209
PDF File: 
PDF icon romj-2019-0209.pdf